The Jackson Laboratory

#Postdoc job of the week: Join the Anczukow lab to investigate how misregulation of alternative RNA splicing contributes to human disease, with a specific focus on cancer: https://bit.ly/49Am0bO #postdocs #postdocjobs

🚨 Attention #AAIC24 attendees 🚨 Stop by The Jackson Laboratory ‘s booth to learn about JAX! Colleagues from JAX Education and Talent Acquisition Careers at The Jackson Laboratory (JAX) will be there to share information about training (predoc, md/phd, and postbacc) and career opportunities. We look forward to meeting you!!

🧠 As reported in Alzheimer’s & Dementia, Greg Carter and collaborators from Stanford University School of Medicine, Emory University, and Sage Bionetworks are offering the first comprehensive ranking of the relative role and significance of every gene and protein in the development of #Alzheimer’s disease, work that will be presented at the Alzheimer's Association® International Conference. #AAIC24 https://lnkd.in/eNj48zz9

JAX Study Director Aaron Rose explores how biological therapeutics are reshaping the traditional drug development process and why #humanizedmodels are essential for advancing biologics programs in this new JAX On-Demand video!

🐁 Ahead of the upcoming Alzheimer's Association® International Conference, we are excited to share a breakthrough in Alzheimer’s research at JAX – researchers are developing a new, genetically susceptible mouse model that aims to replicate key aspects of the disease, using advanced CRISPR gene editing and transcriptomics. #AAIC24 https://lnkd.in/eEtGKKkg

As part of our ongoing #GTB series, we collaborate with a team of clinical experts known as our MCGI GTB advisors. This month, we are thrilled to spotlight Mustafa Khasraw, M.D.! Dr. Khasraw is a Medical Oncologist and Neurooncologist at Duke's Preston Robert Tisch Brain Tumor Center. He is also the Deputy Director of the newly established Center for Cancer Immunotherapy, tasked to speed up clinical research and translation for scientists across all departments at Duke who have made discoveries that show promise for developing new immunotherapies. Dr. Khasraw has trained and worked in several countries, he received his MBChB from Salahaddin University, Kurdistan, Iraq, followed by an M.D. from Groningen University, the Netherlands. He moved to Australia and completed his medical oncology training at Royal North Shore Hospital in Sydney and subsequently completed an additional fellowship at Memorial Sloan-Kettering Cancer Center in New York. Prior to joining Duke in September, 2019, Mustafa Khasraw worked as a medical oncologist in Sydney, Australia where he was also as a Clinical Lead at the Australian National Health & Medical Research Council Clinical Trial Centre at The University of Sydney where he has an ongoing honorary professorship in oncology. He has a leading role in several clinical and translational programs and leads clinical trials with significant laboratory collaborations. He is interested in innovative trials designed to improve outcome of cancer patients. He is lead principal investigator on phase I, II and III multi-centre clinical trials for a number of pharmaceutical and academic groups. He is a Fellow of the Royal Australasian College of Physicians as well as being an Elected Fellow of the Royal College of Physicians (Lon, UK). Dr. Khasraw has been collaborating with the MCGI team since 2019, and his expertise continues to be an invaluable part of our clinical expert team. The Jackson Laboratory

We are excited to be attending the Alzheimer's Association® International Conference (#AAIC24) on dementia research in Philadelphia starting July 28! ➡️ Booth 1343 ⬅️ Visit The Jackson Laboratory's team to chat about Postbaccalaureate, Ph.D., Postdoctoral, and hands-on training opportunities in #dementia and #AlzheimersDisease research to #ENDALZ.

Our thanks to all who attended, our presenters Michael Ellis and Leo Waterston, and The Jackson Laboratory for hosting our Life Sciences Lunch & Learn event in Ellsworth yesterday.

Senior Research Scientist Jason Bubier and Associate Professor Vivek Kumar participated in a panel today during Janet Mills’ 6th annual Opioid Response Summit in Auburn, Maine. Michael McKernan, director, Government and Community relations, moderated the panel, which focused on addiction research, and also included Professor Tamara King, Ph.D., who studies the biology of pain at the University of New England. The group discussed the genetics of addiction and overdose, the importance of employing available interventions, and how educating the public on the science of substance use disorders can help in reducing stigma surrounding addiction. Learn more about addiction research at JAX: https://lnkd.in/e_yXak24

📓 New in the European Journal of Human Genetics from Nature Portfolio, "Speech and language classification in the human phenotype ontology" with Ben Coleman & Peter N Robinson: https://lnkd.in/ghE-Vv3v #jaxresearch